Paper36768977
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism.
Tian LY and 2 others. Int J Mol Sci, 2023. Cited by 295 papers, by iCite.
Cite this record
ConductScience Library. The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism. Papers, record 36768977. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36768977
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Liver Neoplasms | Major topic |
| Humans | |
| Proto-Oncogene Proteins c-akt | |
| Phosphatidylinositol 3-Kinases | |
| Cell Line, Tumor | |
| Signal Transduction | |
| TOR Serine-Threonine Kinases |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 202106010223 | China Scholarship Council | PubMed |
Source PubMed
References152
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32681102 | A combination of AZD5363 and FH5363 induces lethal autophagy in transformed hepatocytes. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32681102 | PubMed |
| 2 | 21233853 | Metabolism, migration and memory in cytotoxic T cells. | Nat Rev Immunol | 2011 | https://conductscience.org/library/papers/21233853 | PubMed |
| 3 | 35276232 | Metabolic tricks of cancer cells. | Biochim Biophys Acta Rev Cancer | 2022 | https://conductscience.org/library/papers/35276232 | PubMed |
| 4 | 35169125 | UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35169125 | PubMed |
| 5 | 25492937 | Foxp3-mediated inhibition of Akt inhibits Glut1 (glucose transporter 1) expression in human T regulatory cells. | J Leukoc Biol | 2015 | https://conductscience.org/library/papers/25492937 | PubMed |
| 6 | 34123854 | Targeting Pyrimidine Metabolism in the Era of Precision Cancer Medicine. | Front Oncol | 2021 | https://conductscience.org/library/papers/34123854 | PubMed |
| 7 | 26321679 | Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. | Cell | 2015 | https://conductscience.org/library/papers/26321679 | PubMed |
| 8 | 30312701 | Knockdown of FOXK1 suppresses liver cancer cell viability by inhibiting glycolysis. | Life Sci | 2018 | https://conductscience.org/library/papers/30312701 | PubMed |
| 9 | 25533673 | PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting. | Nat Rev Cancer | 2015 | https://conductscience.org/library/papers/25533673 | PubMed |
| 10 | 32738450 | p53 haploinsufficiency and increased mTOR signalling define a subset of aggressive hepatocellular carcinoma. | J Hepatol | 2021 | https://conductscience.org/library/papers/32738450 | PubMed |
| 11 | 21128229 | Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. | Int J Cancer | 2011 | https://conductscience.org/library/papers/21128229 | PubMed |
| 12 | 24981175 | Akt phosphorylation and regulation of transketolase is a nodal point for amino acid control of purine synthesis. | Mol Cell | 2014 | https://conductscience.org/library/papers/24981175 | PubMed |
| 13 | 32934330 | Exploring the NK cell platform for cancer immunotherapy. | Nat Rev Clin Oncol | 2021 | https://conductscience.org/library/papers/32934330 | PubMed |
| 14 | 34433044 | Loss of tyrosine catabolic enzyme HPD promotes glutamine anaplerosis through mTOR signaling in liver cancer. | Cell Rep | 2021 | https://conductscience.org/library/papers/34433044 | PubMed |
| 15 | 32070029 | Activation of mTOR Signaling Pathway in Hepatocellular Carcinoma. | Int J Mol Sci | 2020 | https://conductscience.org/library/papers/32070029 | PubMed |
| 16 | 18473854 | Arginine deprivation as a targeted therapy for cancer. | Curr Pharm Des | 2008 | https://conductscience.org/library/papers/18473854 | PubMed |
| 17 | 30809309 | LINC01554-Mediated Glucose Metabolism Reprogramming Suppresses Tumorigenicity in Hepatocellular Carcinoma via Downregulating PKM2 Expression and Inhibiting Akt/mTOR Signaling Pathway. | Theranostics | 2019 | https://conductscience.org/library/papers/30809309 | PubMed |
| 18 | 26629311 | Targeting amino acid metabolism in cancer growth and anti-tumor immune response. | World J Biol Chem | 2015 | https://conductscience.org/library/papers/26629311 | PubMed |
| 19 | 31387985 | Hydrogen peroxide inducible clone-5 sustains NADPH oxidase-dependent reactive oxygen species-c-jun N-terminal kinase signaling in hepatocellular carcinoma. | Oncogenesis | 2019 | https://conductscience.org/library/papers/31387985 | PubMed |
| 20 | 24055031 | A class II phosphoinositide 3-kinase plays an indispensable role in hepatitis C virus replication. | Biochem Biophys Res Commun | 2013 | https://conductscience.org/library/papers/24055031 | PubMed |
Cited by222
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 295 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42978971 | Crosstalk between PI3K/AKT signaling and epigenetic regulation in hepatocellular carcinoma: molecular mechanisms and therapeutic opportunities. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42978971 | PubMed |
| 42940018 | Copper Nanoparticles at Optimized Concentrations Exhibit Minimal Intrinsic Biological Effects in Hepatocellular Carcinoma Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940018 | PubMed |
| 42939944 | Gilteritinib Suppresses Hepatocellular Carcinoma Cells in Association with Reduced Calpain-1 Expression and Inhibition of STAT3/AKT Signaling. | Biomedicines | 2026 | https://conductscience.org/library/papers/42939944 | PubMed |
| 42890543 | The dual IGF-1R/IR blocker, Linsitinib, modulates human orbital fibroblast activity and proliferation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42890543 | PubMed |
| 42858308 | Tissue-Specific Isolation of Hepatocyte Extracellular Vesicles From Human Plasma Enables Tissue-Resolved Proteomic and miRNA Profiling. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/42858308 | PubMed |
| 42799406 | Understanding the Potential of Antibody-Drug Conjugates Functionalized Engineered Exosomes in Hepatocellular Carcinoma Therapy: A Comprehensive Narrative Review. | Health Sci Rep | 2026 | https://conductscience.org/library/papers/42799406 | PubMed |
| 42793207 | Rethinking Drug Resistance in Acute Promyelocytic Leukemia: The Regulated Cell Death Network as an Integrative Framework. | Biomolecules | 2026 | https://conductscience.org/library/papers/42793207 | PubMed |
| 42792873 | Concurrent Inhibition of AKT and GLUT1 Reveals Endpoint-Specific Effects on Glucose Metabolism and Cell Death in HepG2 Hepatocyte-Derived Cells. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792873 | PubMed |
| 42792787 | Molecular Signaling Pathways, Regulatory and Coactivator Networks, and Emerging Mechanisms in Hepatocellular Carcinoma. | Biomedicines | 2026 | https://conductscience.org/library/papers/42792787 | PubMed |
| 42769963 | Immune cell-derived exosomes in cancer: double-edged mechanisms of antitumor immunity and tumor progression. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769963 | PubMed |
| 42747623 | Amino acid transporters in hepatocellular carcinoma: Gatekeepers of metabolic reprogramming. | Mol Biol Rep | 2026 | https://conductscience.org/library/papers/42747623 | PubMed |
| 42739743 | Comparison of the Effects of Sorafenib and Stem Cell Secretome on HepG2 Cancer Cells with Respect to the Ras/Raf/MEK/ERK Pathway. | J Clin Med | 2026 | https://conductscience.org/library/papers/42739743 | PubMed |
| 42726806 | Identification of functional genes and immune cell infiltration analysis in liposarcoma. | PLoS One | 2026 | https://conductscience.org/library/papers/42726806 | PubMed |
| 42724077 | Lipid Metabolism-related lncRNA Model Identifies AC026412.3 as a Driver of Fatty Acid β-oxidation in Hepatocellular Carcinoma. | J Clin Transl Hepatol | 2026 | https://conductscience.org/library/papers/42724077 | PubMed |
| 42667530 | Targeting the PI3K/AKT/mTOR pathway in gastrointestinal cancers: a comprehensive review of mechanisms, preclinical evidence, and clinical challenges. | Med Oncol | 2026 | https://conductscience.org/library/papers/42667530 | PubMed |
| 42653240 | Single-Cell Analysis Reveals STARD10 as a Fatty Acid Metabolism Regulator of Breast Cancer Progression via the PI3K/Akt Pathway. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653240 | PubMed |
| 42652115 | Overcoming mTOR Inhibitor Resistance: From Biological Basis to Therapeutic Strategies. | Biomedicines | 2026 | https://conductscience.org/library/papers/42652115 | PubMed |
| 42634207 | Emetine and Its Derivatives as Anticancer Agents Targeting the PI3K/AKT/mTOR Pathway: A Narrative Review of Mechanisms, Pharmacology, and Clinical Insights. | J Cell Mol Med | 2026 | https://conductscience.org/library/papers/42634207 | PubMed |
| 42619501 | Astragaloside IV and rapamycin co-loaded bone marrow mesenchymal stem cell-derived exosome nanocarriers for targeted modulation of the PI3K/Akt/mTOR pathway in hepatocellular carcinoma. | Nanomedicine (Lond) | 2026 | https://conductscience.org/library/papers/42619501 | PubMed |
| 42587233 | Size-Dependent Differences in the Effects of Low-Dose Selenium Nanoparticles on Chronic Thioacetamide Toxicosis Accompanying HCC Progression in Mice. | Biol Trace Elem Res | 2026 | https://conductscience.org/library/papers/42587233 | PubMed |
Genes74
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36768977
GET https://conductscience.org/api/papers/v1/36768977/references?page=2